Prof Ashok Venkitaraman
He is a collaborative science chair at inStem and NCBS, Bangalore, and also coordinates at the Center for Chemical Biology and Therapeutics (CCBT).
In his exclusive interview with BioSpectrum, Prof Venkitaraman shared some of his research work and collaborations at Cambridge University. He feels that there is tremendous scope for extending cancer research in the academic and industrial sectors in India.
He believes that aspects of such efforts in the UK is a great place for oncology research based start-ups to translate laboratory discoveries to clinical application with the aim of delivering important new medical products.
He says that the best people in research, whether in academia or industry inevitably flock to the best places where they can carry out their research well, which in turn means that it will be important to build excellent institutions to attract such talents.
Q: What are the opportunities available for Indian oncology research start-ups to set foot in the UK?